Veracyte appoints Tom Miller, Ph.D. and Brent Shafer to Board of Directors

VERACYTE, INC.

Appointments effective September 3, 2024; terms until 2025 annual meeting or successor.
Miller joins Regulatory and Compliance Committee; Shafer joins Compensation Committee.
Both eligible for standard non-employee director compensation; no related-party transactions.
No family relationships with existing directors or officers; standard indemnity agreements signed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Tom Miller

Director

VCYT · VERACYTE, INC.

Effective: 2024-09-03
Filed: September 4, 2024, 7:59 PM ET

the Board appointed Tom Miller, Ph.D., and Brent Shafer to serve as directors of the Company, effective immediately.

Appointed

Brent Shafer

Director

VCYT · VERACYTE, INC.

Effective: 2024-09-03
Filed: September 4, 2024, 7:59 PM ET

the Board appointed Tom Miller, Ph.D., and Brent Shafer to serve as directors of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tom Miller was appointed as Director at VERACYTE, INC..

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Tom Miller, Ph.D., and Brent Shafer to serve as directors of the Company, effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Brent Shafer was appointed as Director at VERACYTE, INC..

Action: appointed
Role: Director

Exact text from the filing

the Board appointed Tom Miller, Ph.D., and Brent Shafer to serve as directors of the Company, effective immediately.

View on SEC.gov

VERACYTE, INC. filing history →

Source: SEC EDGAR

accession 0001384101-24-000133

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.